Cosentyx

 Cosentyx (secukinumab) is an injectable biologic used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting a specific protein (IL-17A) involved in inflammation.

Benefits
• Reduces psoriasis plaques and skin flaking
• Helps relieve joint pain in psoriatic arthritis
• Improves mobility in ankylosing spondylitis
• Provides long-term symptom relief for many patients

Dosage
• Typical dose is 150 mg or 300 mg depending on the condition
• Initial loading doses weekly for 5 weeks, followed by monthly maintenance
• Administered as a subcutaneous injection
• Can be given by a healthcare provider or self-injected at home

Warnings and Precautions
• May increase risk of infections
• Avoid if you have active tuberculosis
• Use caution with inflammatory bowel diseases
• Live vaccines should be avoided during treatment

Usage Instructions
• Follow injection training if self-administering
• Rotate injection sites to avoid skin irritation
• Do not inject into inflamed or broken skin
• Report any signs of infection immediately

Storage Information
• Store in the refrigerator at 2°C to 8°C (36°F to 46°F)
• Do not freeze or shake
• Keep in the original packaging
• Allow to reach room temperature before use

Common Side Effects
• Upper respiratory infections
• Diarrhea
• Headache
• Injection site reactions